Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic Myopia
Stopped Funding did not come through as the product was sold to another company.
Conditions
- Myopic Choroidal Neovascular Membrane
Interventions
- DRUG: Intravitreal Pegaptanib
Sponsor
L.V. Prasad Eye Institute
Collaborators